» Download Public Reports
About 1 800 reports
- Company report
- June 2013
- 14 pages
... China prescription drug sales report 2012 9 opportunity in asthma and copd the initial pipeline will target drugs that currently account for over 50% of this market expectations of up to five drugs ...
June 2013
... Manufacturing innovative approaches to expand influenza vaccine production capabilities alliances and partnerships in driving vaccine development in asia evaluating novel adjuvant ...
May 2013
... Company drug name therapeutic area innovator company generic version of market size aurobindo pharma cefadroxil/cefadroxil hemihydrate tablets anti-infective warner chilcott duricef na aurobindo pharma ...
May 2013
... tramadol hydrochloride pain management tramadol grunethal gmbh na cadila healthcare clopidogrel bisulfate anti-coagulant bms \ sanofi aventis plavix us$ 6 billion cadila healthcare donepezil hydrochloride ...
May 2013
... Adulterants were found to be therapeutic substances associated with the specific indications of the products such as adulterant for sexual enhancement drugs ( sildenafil, tadalafil ), pain relieving drugs ...
May 2013
... Of generic medicines Reliable & sustainable national financing mechanism To ensure the poor and underprivileged are not denied access to essential medicines generic policies price of drugs ...
May 2013
... Care markets markets are dynamic, which means that outcomes can change quickly. Results suggest that consumers partially infer drug quality. Bennett and yin (uchicago and bu) the market for high ...
May 2013
... And lower drug prices. The gradual opening of provincial-level tenders could further intensify the competition in the next few quarters. Yet we believe the company will continue to grow faster than ...
» Purchase Premium Reports
(From $ 75 - $ 4 995)
About 1 000 reports
- $ 4 995
- Industry report
- May 2013
- by Global Data
PharmaPoint: Hepatitis C Virus - Japan Drug Forecast and Market Analysis Summary GlobalData has released its new Country report, ?PharmaPoint: Hepatitis C Virus - Japan Drug Forecast and Market Analysis?. ...
May 2013
$ 4 995
PharmaPoint: Hepatitis C Virus - China Drug Forecast and Market Analysis Summary GlobalData has released its new Country report, ?PharmaPoint: Hepatitis C Virus - China Drug Forecast and Market Analysis?. ...
May 2013
$ 5 174
This market research report package offers a perspective on the actual market situation, trends and future outlook for vaccines in the top 10 global countries. The studies provide essential market information ...
June 2013
$ 4 180
Research Background In the past few years, dairy farming has been developing rapidly in China. Especially dairy farms above 100 head inventory have been established in large number. Simultaneously, the ...
April 2013
$ 3 500
Seasonal Influenza Vaccine Market in Asia-Pacific to 2018 - Positive Impact of Government Support Offset by Limited Production Capacity, High Investment and Strict Regulations as Barriers to New Entrants ...
April 2013
$ 3 500
Adult and Adolescent Vaccines Market to 2018 - Promising Novel Candidates in Late-Stage Development and Prevnar Approval for Use in Adults to Drive Growth Summary The leading business intelligence provide ...
May 2013
$ 3 500
Travel Vaccines Market to 2019 - Hepatitis A, Japanese Encephalitis and Meningococcal Vaccine Segments to Drive Growth Summary The leading business intelligence provider GBI Research has released its ...